Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LHW090 in Resistant Hypertension
NCT02515331Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of LHW090 in resistant hypertension (RH), sponsored by Novartis. Started Nov 2015; status: completed.
02
Drugs
LHW090
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT02515331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02515331.